Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
13th August 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that since July...
Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
13th August 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that since July...
Global Med Technologies Announces Acquisition of eDonor(R): One of the Industry's Premier Technology Platforms for Donor Recruitment, Scheduling and Retention
1st August 2008 DENVER, August 1 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC
Bulletin Board: GLOB), an international e-Health, medical information
technology company, today...
ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
30th July 2008 LEUVEN, Belgium, July 30 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology
company focused on eye disease, vascular disease and cancer, today announces
that a group of...
Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
24th July 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, July 24 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the
development of microRNA-based diagnostics and therapeutics, announced...
Roche Proposes to buy Full Stake in Genentech - Interview With Chairman
21st July 2008 LONDON, July 21 /PRNewswire/ -- Roche, the healthcare company, announced today that it has proposed to
acquire the outstanding publicly held interest in biotech company Genentech
for US$89.00 per...
SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group
9th July 2008 SAINT CHARLES, Minnesota, July 9 /PRNewswire/ -- SmoothToe, the only brand of diabetic socks available anywhere in the
world with a Lifetime Blister Free Guarantee as well as a Five Year...
Gen-Probe Does Not Intend to Increase Offer to Acquire Innogenetics
9th July 2008 SAN DIEGO, July 9 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company
does not intend to increase the value of its conditional tender offer to
acquire 100% of the...
t+ Medical Acquires Vivatec Ltd
9th July 2008 OXFORD, England, July 9 /PRNewswire/ -- t+ Medical is delighted to announce the acquisition of Vivatec Ltd.
Following a period of rapid expansion including a successful launch of t+
Clinical into the...
Johnson & Johnson Nordic AB Acquires Amic
18th June 2008 SOLLENTUNA, Sweden, June 18 /PRNewswire/ -- Johnson & Johnson Nordic AB, a Johnson & Johnson company, today announced
the acquisition of Amic, a privately held Swedish developer of in...
Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
16th June 2008 CHARENTON-LE-PONT, France, June 16 /PRNewswire/ -- Essilor and the Swiss company Schweiter Technologies AG announced today
that they have signed a share purchase agreement whereby Essilor will...
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
3rd June 2008 SAN DIEGO, June 3 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic
acid diagnostics for human disease, announced today that it has launched a
conditional tender...
Quintiles Signs Agreement to Acquire Eidetics
7th May 2008 RESEARCH TRIANGLE PARK, North Carolina, May 7 /PRNewswire/ -- Quintiles Transnational Corp. today announced that it has signed an
agreement to acquire Eidetics, a privately held decision-analytics...
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
6th May 2008 CORAL GABLES, Florida, May 6 /PRNewswire/ -- Stiefel Laboratories, Inc., the world's largest independent
pharmaceutical company specializing in dermatology, announced today that it
has acquired ABR...
vision4health Acquires MOLIS From SYSMEX
1st May 2008 WILEN, Germany, May 1 /PRNewswire/ -- Effective immediately, vision4health has acquired the MOLIS laboratory
information system division from the Japanese SYSMEX Group. The company, set
up in 2007...
Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
25th April 2008 PATERSON, New Jersey, April 25 /PRNewswire/ -- Amneal Pharmaceuticals, LLC is pleased to announce the execution of an
Asset Purchase Agreement for Amneal's wholly-owned subsidiary,...
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
24th April 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, April 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces the acquisition of...
TopoTarget Successfully Buys Back Full Control of Belinostat
22nd April 2008 COPENHAGEN, April 22 /PRNewswire/ -- TopoTarget A/S (OMX: TOPO) today announced that the company has
successfully gained full control of belinostat so that global rights are now
wholly owned by the...
Excalibur Celebrates PIramed Sale With 'Substantial Cash Return' to Investors
15th April 2008 GLASGOW, Scotland, April 15 /PRNewswire/ -- Excalibur, the new international investment house launched by Sir
Christopher Evans, today (Tuesday) welcomed the sale of PIramed to Roche.
(Photo:...
Galderma Completes Acquisition of CollaGenex
11th April 2008 LAUSANNE, Switzerland, April 11 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused
on dermatology, today announced that its U.S. holding company,...
Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
8th April 2008 LONDON, April 8 /PRNewswire/ -- The Board of Molecular Vision today announces that discussions with
Acrongenomics on the proposed acquisition of Molecular Vision have now
ceased. Acrongenomics has...
Galderma Completes Tender Offer for CollaGenex
7th April 2008 LAUSANNE, Switzerland, April 7 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused
on dermatology, today announced that its U.S. holding company,...
Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
4th April 2008 CHARENTON-LE-PONT, France, April 4 /PRNewswire/ -- Essilor is pursuing its external growth strategy in Italy and
the United States.
The Group has stepped up its development in Italy with...
VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
1st April 2008 WEST CHESTER, Pennsylvania, April 1 /PRNewswire/ -- VWR International, LLC, a leading global laboratory supply company, today
announced that it has acquired Jencons (Scientific) Limited, a UK...
Global Med Technologies(R), Inc. Signs Purchase Agreement to Acquire Inlog, SA, a European Medical Software Firm
31st March 2008 DENVER, March 31 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC
Bulletin Board: GLOB), an international e-Health, medical information
technology company, today...
Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
19th March 2008 LAUSANNE, Switzerland, March 19 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused
on dermatology, today announced that its U.S. holding company,...
Hikma - 2007 Preliminary Results Interviews With CEO and CFO
18th March 2008 LONDON, March 18 /PRNewswire/ -- In video interviews Said Darwazah, CEO, and Bassam Kanaan, CFO, discuss
Hikma's 2007 performance, financing and acquisitions, plus what they are
expecting from the...
Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
14th March 2008 COPENHAGEN, Denmark and REDWOOD CITY, California, March 14 /PRNewswire/ --
- Summary: Genmab's Acquisition of PDL BioPharma's Antibody Manufacturing
Facility has Closed.
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
11th March 2008 DOYLESTOWN, Pennsylvania and OXFORD, England, March 11 /PRNewswire/ --
- Acquisition of US Infrastructure Completes Build of EUSA's
Transatlantic Commercialization Platform
Acrongenomics Acquires Equity Stake in Molecular Vision
4th February 2008 GENEVA, February 4 /PRNewswire/ -- Acrongenomics, Inc. (OTC: AGNM) is pleased to announce that they have
acquired a 10.9% interest in Molecular Vision Limited, on a fully diluted
basis. The cash...
2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DUSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just
completed another record year. In 2007 the company achieved sales of
EUR957.7m, up by 48.1%;...
2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just
completed another record year. In 2007 the company achieved sales of
EUR957.7m, up by...
Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
1st February 2008 LONDON, February 1 /PRNewswire/ -- Chiltern, the global contract research organization, announced today that
it has acquired the business of Drug Development Solutions ('DDS'), a leading
Phase 1 unit...